1. Home
  2. BLCO vs TENB Comparison

BLCO vs TENB Comparison

Compare BLCO & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • TENB
  • Stock Information
  • Founded
  • BLCO 1853
  • TENB 2002
  • Country
  • BLCO Canada
  • TENB United States
  • Employees
  • BLCO N/A
  • TENB N/A
  • Industry
  • BLCO Ophthalmic Goods
  • TENB Computer Software: Prepackaged Software
  • Sector
  • BLCO Health Care
  • TENB Technology
  • Exchange
  • BLCO Nasdaq
  • TENB Nasdaq
  • Market Cap
  • BLCO 5.7B
  • TENB 4.9B
  • IPO Year
  • BLCO 2022
  • TENB 2018
  • Fundamental
  • Price
  • BLCO $15.91
  • TENB $39.11
  • Analyst Decision
  • BLCO Buy
  • TENB Buy
  • Analyst Count
  • BLCO 10
  • TENB 17
  • Target Price
  • BLCO $18.50
  • TENB $52.94
  • AVG Volume (30 Days)
  • BLCO 307.4K
  • TENB 751.2K
  • Earning Date
  • BLCO 10-30-2024
  • TENB 10-30-2024
  • Dividend Yield
  • BLCO N/A
  • TENB N/A
  • EPS Growth
  • BLCO N/A
  • TENB N/A
  • EPS
  • BLCO N/A
  • TENB N/A
  • Revenue
  • BLCO $4,495,000,000.00
  • TENB $852,037,000.00
  • Revenue This Year
  • BLCO $16.69
  • TENB $14.08
  • Revenue Next Year
  • BLCO $6.37
  • TENB $11.39
  • P/E Ratio
  • BLCO N/A
  • TENB N/A
  • Revenue Growth
  • BLCO 15.14
  • TENB 14.62
  • 52 Week Low
  • BLCO $13.16
  • TENB $33.85
  • 52 Week High
  • BLCO $17.92
  • TENB $53.50
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 47.87
  • TENB 35.77
  • Support Level
  • BLCO $15.83
  • TENB $39.11
  • Resistance Level
  • BLCO $16.75
  • TENB $42.54
  • Average True Range (ATR)
  • BLCO 0.40
  • TENB 1.08
  • MACD
  • BLCO -0.02
  • TENB -0.20
  • Stochastic Oscillator
  • BLCO 22.24
  • TENB 5.91

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: